Cited by 2,712Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromeAutoimmune and Inflammatory Disorders

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Inflammatory Bowel Disease

Open access

Abraham, Clara, Cho, Judy H.·2009·New England Journal of Medicine

Open this paper in CoChat — free account Open PDF

Abstract

more than 50 distinct clinical collections, which can be used as convenient entry points to clinical content.In each collection, articles are cited in reverse chronologic order, with the most recent first.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra0804647

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S. K., Wise, R. P., Mirabile‐Levens, E., Kasznica, J. M., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,683
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554

Flagged first, then by citations

Show all 104 references

Research works printed but not linked: 6

Musch MW, 2002, J Clin Invest, 110, 1739, 10.1172/JCI0215695 · DOI
Vijay-Kumar M, 2007, J Clin Invest, 117, 3909
10.1172/JCI19229 · DOI
Kamada N, 2008, J Clin Invest, 118, 2269
Watanabe T, 2008, J Clin Invest, 118, 545
Sugimoto K, 2008, J Clin Invest, 118, 534

Sorted by citations

Items 401–500 of 1,008

Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective
Zwicky, P., Unger, S., & Becher, B. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191123 · Cited by 91
Adaptation of adherent-invasive E. coli to gut environment: Impact on flagellum expression and bacterial colonization ability
Sevrin, G., Massier, S., Chassaing, B., Agus, A., Delmas, J., Denizot, J., Billard, E., & Barnich, N. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1421886 · Cited by 98
Role of Vitamin D in the Natural History of Inflammatory Bowel Disease
Nielsen, O. H., Rejnmark, L., & Moss, A. C. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy025 · Cited by 97
Time to dissect the autoimmune etiology of cancer antibody immunotherapy
Dougan, M. L., & Pietropaolo, M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131194 · Cited by 92
Endothelial dysfunction and its relation in different disorders: Recent update
Ray, A., Maharana, K. C., Meenakshi, S., & Singh, S. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100084 · Cited by 91
Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double‐blind, placebo‐controlled trial
Ou, C. ‐., Kuo, H., Wang, L., Hsu, T. ‐., Chuang, H., Liu, C. ‐., Chang, J., Yu, H., & Yang, K. D. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04037.x · Cited by 91
Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora
Yao, W., Gong, J., Zhu, W., Tian, H., Ding, C., Gu, L., Li, N., & Li, J. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0869-2 · Cited by 97
The Plasma Membrane: A Platform for Intra- and Intercellular Redox Signaling
Nordzieke, D. E., & Medraño-Fernandez, I. (2018) · Antioxidants · doi:10.3390/antiox7110168 · Cited by 90
The matricellular protein CCN1 in tissue injury repair
Kim, K., Won, J. H., Cheng, N., & Lau, L. F. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0450-x · Cited by 89
Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway
Dou, W., Zhang, J., Li, H., Kortagere, S., Sun, K., Ding, L., Ren, G., Wang, Z., & Mani, S. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.04.006 · Cited by 90
Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation
Powell, N., Lo, J. W., Biancheri, P., Vossenkämper, A., Pantazi, E. D., Walker, A. W., Stolarczyk, É., Ammoscato, F., Goldberg, R., Scott, P., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.017 · Cited by 86
Assessment of mucosal healing in inflammatory bowel disease: review
Dulai, P. S., Levesque, B. G., Feagan, B. G., D’Haens, G., & Sandborn, W. J. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1974 · Cited by 89
JAK inhibition in inflammatory bowel disease
Olivera, P. A., Danese, S., & Peyrin‐Biroulet, L. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1291342 · Cited by 89
Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
Su, H.-J., Chiu, Y., Chiu, C.-T., Lin, Y.-C., Wang, C., Hsieh, J.-Y., & Wei, S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.07.005 · Cited by 89
The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease
Eder, P., Adler, M., Dobrowolska, A., Kamhieh‐Milz, J., & Witowski, J. (2019) · Cells · doi:10.3390/cells8060628 · Cited by 88
CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders
Lu, C., Amin, M. A., & Fox, D. A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900868 · Cited by 91
Inflammatory Bowel Disease: The Classic Gastrointestinal Autoimmune Disease
Kaistha, A., & Levine, J. J. (2014) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2014.10.003 · Cited by 89
Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset Inflammatory Bowel Disease
Dhillon, S. S., Mastropaolo, L. A., Murchie, R., Griffiths, C., Thoeni, C. E., Elkadri, A. A., Xu, W., Mack, A., Walters, T. D., Guo, C., et al. (2014) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2013.17 · Cited by 85
Midkine in Inflammation
Weckbach, L. T., Muramatsu, T., & Walzog, B. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/517152 · Cited by 89
Differential Effect of Genetic Burden on Disease Phenotypes in Crohn's Disease and Ulcerative Colitis: Analysis of a North American Cohort
Ananthakrishnan, A. N., Huang, H., Nguyen, D. D., Sauk, J. S., Yajnik, V., & Xavier, R. J. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.464 · Cited by 89
Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases
Caetano, M. A. F., & Castelucci, P. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i28.9985 · Cited by 92
Association between high dietary intake of the n−3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease
Chan, S. S. M., Luben, R., Olsen, A., Tjønneland, A. M., Kaaks, R., Lindgren, S. C., Grip, O., Bergmann, M. M., Boeing, H., Hallmans, G., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12670 · Cited by 93
In Vivo Systems Analysis Identifies Spatial and Temporal Aspects of the Modulation of TNF-α–Induced Apoptosis and Proliferation by MAPKs
Lau, K. S., Juchheim, A. M., Cavaliere, K., Philips, S. R., Lauffenburger, D. A., & Haigis, K. M. (2011) · Science Signaling · doi:10.1126/scisignal.2001338 · Cited by 87
Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease
Mao, H., Yang, W., Lee, P. P. W., Ho, M., Yang, J., Zeng, S., Chong, C.-Y., Lee, T.-L., Tu, W., & Lau, Y.-L. (2012) · Genes and Immunity · doi:10.1038/gene.2012.8 · Cited by 87
Gut microbiome: a new player in gastrointestinal disease
Gorkiewicz, G., & Moschen, A. R. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2277-x · Cited by 95
Selenium and Selenoproteins in Gut Inflammation—A Review
Nettleford, S. K., & Prabhu, K. S. (2018) · Antioxidants · doi:10.3390/antiox7030036 · Cited by 87
Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis
Silva, I., Pinto, R. M. A., & Mateus, V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101574 · Cited by 87
NOD Signaling and Cell Death
Heim, V. J., Stafford, C. A., & Nachbur, U. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00208 · Cited by 89
“The strongest evidence that suggests direct involvement of NOD signaling pathways in regulating caspase functions stem from observations that NOD1 and NOD2 can induce IL-1β through NF-κB and MAPK pathways in multiple human and mouse cell populations, including myeloid-derived cells (Li et al., 2004; Watanabe et al., 2…”
Background
Arginase impedes the resolution of colitis by altering the microbiome and metabolome
Baier, J., Gänsbauer, M., Gießler, C., Arnold, H., Muske, M., Schleicher, U., Lukassen, S., Ekici, A. B., Rauh, M., Daniel, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci126923 · Cited by 87
“Both inflammatory bowel diseases (IBDs) are thought to result from dysregulated interactions of the commensal microbiota, the intestinal epithelium (IE), and the mucosal humoral and cellular immune network (1).”
Background
Beyond Appendicitis: Common and Uncommon Gastrointestinal Causes of Right Lower Quadrant Abdominal Pain at Multidetector CT
Purysko, A. S., Remer, E. M., Filho, H. M. L., Bittencourt, L. K., Lima, R. V., & Racy, D. J. (2011) · Radiographics · doi:10.1148/rg.314105065 · Cited by 87
Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease
Nguyen, T. T., Trinh, N., Tran, H. N., Tran, H. T., Le, P. Q., Ngo, D., Tran‐Van, H., Toi, V. V., Vong, L. B., & Nagasaki, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.042 · Cited by 89
Helicobacter pylori–specific Protection Against Inflammatory Bowel Disease Requires the NLRP3 Inflammasome and IL-18
Engler, D. B., Leonardi, I., Hartung, M. L., Kyburz, A., Spath, S., Becher, B., Rogler, G., & Mueller, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000318 · Cited by 86
Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages
Song, J.-Y., Kang, H. J., Hong, J. S., Kim, C. J., Shim, J., Lee, C. W., & Choi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09827-5 · Cited by 86
An Update of Research Animal Models of Inflammatory Bowel Disease
Baydi, Z., Limami, Y., Khalki, L., Zaïd, N., Naya, A., Mtairag, E. M., Oudghiri, M., & Zaid, Y. (2021) · The Scientific World JOURNAL · doi:10.1155/2021/7479540 · Cited by 86
“In 1975, the propagation of ten lines of “senescenceprone” mice SAMP1 [72] resulted from brother-sister mating with a selection of breeders with accelerated senescence, shortened life span, and other signs of pathology.”
Background
EPA- and DHA-derived resolvins' actions in inflammatory bowel disease
Schwanke, R. C., Marcon, R., Bento, A. F., & Calixto, J. Β. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.050 · Cited by 85
“…still remains elusive, but a large amount of evidence suggests that genetic factors increase the susceptibility to it, and environmental factors seem to be responsible for the onset of the disease (Abraham and Cho, 2009; Baumgart et al., 2010; Strober et al., 2007; Xavier and Podolsky, 2007).”
Background
Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases
Holmer, A. K., & Singh, S. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1646127 · Cited by 84
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 97
New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease
Shores, D. R., Binion, D. G., Freeman, B. Α., & Baker, P. R. S. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21560 · Cited by 86
The Membrane-Bound Mucin Muc1 Regulates T Helper 17-Cell Responses and Colitis in Mice
Nishida, A., Lau, C. W., Zhang, M., Andoh, A., Shi, H. N., Mizoguchi, E., & Mizoguchi, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.12.036 · Cited by 84
Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohnʼs Disease
Pringle, P. L., Stewart, K. O., Peloquin, J. M., Sturgeon, H. C., Nguyen, D. D., Sauk, J. S., Garber, J. J., Yajnik, V., Ananthakrishnan, A. N., Chan, A. T., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000498 · Cited by 86
Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease
Qiao, H., Fang, D., Chen, J., Sun, Y., Chen, K., Di, L., Li, J., Chen, Z., Chen, J., & Gao, Y. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1245367 · Cited by 84
Inflammatory Bowel Disease
Szigethy, E., McLafferty, L. P., & Goyal, A. (2010) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2010.01.007 · Cited by 84
Immune deficiency–related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency
Lemoine, R., Schmid, J. P., Farin, H. F., Bigorgne, A., Debré, M., Sepulveda, F. E., Héritier, S., Lemale, J., Talbotec, C., Rieux‐Laucat, F., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.019 · Cited by 84
T Cell–Macrophage Interactions and Granuloma Formation in Vasculitis
Hilhorst, M. L., Shirai, T., Berry, G. J., Goronzy, J. J., & Weyand, C. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00432 · Cited by 84
Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis
Þorsteinsdóttir, S., Guðjόnsson, Þ., Nielsen, O. H., Vainer, B., & Seidelin, J. B. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.96 · Cited by 83
An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease
Huang, Z. D., Gan, J., Jia, L., Guo, G., Wang, C., Zang, Y., Ding, Z., Chen, J., Zhang, J., & Dong, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.013 · Cited by 83
Emerging actions of the nuclear receptor LRH-1 in the gut
Fernández-Marcos, P. J., Auwerx, J. H., & Schoonjans, K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.010 · Cited by 83
Control of inflammation by stromal Hedgehog pathway activation restrains colitis
Lee, J. J., Rothenberg, M. E., Seeley, E. S., Zimdahl, B., Kawano, S., Lu, W.-J., Shin, K., Sakata, T., Chen, J., Diehn, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616447113 · Cited by 83
Activation of Pattern Recognition Receptors Up-Regulates Metallothioneins, Thereby Increasing Intracellular Accumulation of Zinc, Autophagy, and Bacterial Clearance by Macrophages
Lahiri, A., & Abraham, C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.024 · Cited by 84
Microbiome of the Paranasal Sinuses: Update and Literature Review
Lee, J. T., Frank, D. N., & Ramakrishnan, V. R. (2016) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2016.30.4255 · Cited by 82
A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation
Mezzasalma, V., Manfrini, E., Ferri, E., Sandionigi, A., La Ferla, B., Schiano, I., Michelotti, A., Nobile, V., Labra, M., & Di Gennaro, P. (2016) · BioMed Research International · doi:10.1155/2016/4740907 · Cited by 81
Helminths and the microbiota: parts of the hygiene hypothesis
Loke, P., & Lim, Y. A. L. (2015) · Parasite Immunology · doi:10.1111/pim.12193 · Cited by 80
Structured physical activity interventions as a complementary therapy for patients with inflammatory bowel disease – a scoping review and practical implications
Eckert, K. G., Abbasi-Neureither, I., Köppel, M., & Huber, G. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1034-9 · Cited by 81
Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling
Kim, S. W., Kim, S., Son, M., Cheon, J. H., & Park, Y. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-59314-7 · Cited by 81
The possible mechanism of the protective effect of a sulfated polysaccharide from Gracilaria Lemaneiformis against colitis induced by dextran sulfate sodium in mice
Han, R., Ma, Y., Xiao, J., You, L., Pedišić, S., & Liao, L. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112001 · Cited by 81
Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity
Lin, J., Welker, N. C., Zhao, Z., Li, Y., Zhang, J., Reuss, S. A., Zhang, X., Lee, H., Liu, Y., & Bronner, M. P. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.152 · Cited by 81
Prevalence of Apical Periodontitis in Patients with Inflammatory Bowel Diseases: A Retrospective Clinical Study
Piras, V., Usai, P., Mezzena, S., Susnik, M., Ideo, F., Schirru, E., & Cotti, E. (2017) · Journal of Endodontics · doi:10.1016/j.joen.2016.11.004 · Cited by 80
Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities
Chen, Y.-C., Gad, S. F., Chobisa, D., Li, Y., & Yeo, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.025 · Cited by 80
“Disease (CD) and Ulcerative Colitis (UC), describes a group of intestinal disorders resulting from inappropriate inflammatory response to intestinal microorganisms in genetically sensitive patients [279].”
Background
NOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79
A Systematic Review of Measurement of Endoscopic Disease Activity and Mucosal Healing in Crohnʼs Disease
Khanna, R., Bouguen, G., Feagan, B. G., D’Haens, G., Sandborn, W. J., Dubcenco, E., Baker, K. A., & Levesque, B. G. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000131 · Cited by 79
An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data
Wadsworth, W. D., Argiento, R., Guindani, M., Galloway-Peña, J., Shelburne, S. A., & Vannucci, M. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1516-0 · Cited by 84
Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease
Sahoo, D., Swanson, L., Sayed, I. M., Katkar, G. D., Ibeawuchi, S.-R., Mittal, Y., Pranadinata, R. F., Tindle, C., Fuller, M., Stec, D. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24470-5 · Cited by 81
Intestinal Alkaline Phosphatase: A Review of This Enzyme Role in the Intestinal Barrier Function
Santos, G. M., Ismael, S., Morais, J., Araújo, J., Faria, A., Calhau, C., & Marques, C. (2022) · Microorganisms · doi:10.3390/microorganisms10040746 · Cited by 73
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn’s Disease
Mortha, A., Remark, R., Valle, D. M. D., Chuang, L.-S. F., Chai, Z., Alves, I., Azevedo, C. M., Gaifem, J., Martin, J., Petralia, F., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.029 · Cited by 79
Interleukin-34 sustains inflammatory pathways in the gut
Franzè, E., Monteleone, I., Cupi, M. L., Mancia, P., Caprioli, F., Marafini, I., Colantoni, A., Ortenzi, A., Laudisi, F., Sica, G., et al. (2015) · Clinical Science · doi:10.1042/cs20150132 · Cited by 79
The multiple and enigmatic roles of guanylyl cyclase C in intestinal homeostasis
Arshad, N., & Visweswariah, S. S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.028 · Cited by 76
Quantification and Monitoring of Inflammation in Murine Inflammatory Bowel Disease with Targeted Contrast-enhanced US
Deshpande, N., Lutz, A. M., Ren, Y., Foygel, K., Tian, L., Schneider, M., Pai, R. K., Pasricha, P. J., & Willmann, J. K. (2011) · Radiology · doi:10.1148/radiol.11110323 · Cited by 79
Cyanidin-3-O-Glucoside Modulates the In Vitro Inflammatory Crosstalk between Intestinal Epithelial and Endothelial Cells
Ferrari, D., Cimino, F., Fratantonio, D., Molonia, M. S., Bashllari, R., Busà, R., Saija, A., & Speciale, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/3454023 · Cited by 79
Lactobacillus acidophilus suppresses intestinal inflammation by inhibiting endoplasmic reticulum stress
Kim, D. H., Kim, S., Lee, J. H., Kim, J. H., Che, X., Woo, H. J., Seo, D. H., Kim, T. I., Kim, W. H., Kim, S. W., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14362 · Cited by 78
Psychological co-morbidities in COPD: Targeting systemic inflammation, a benefit for both?
Pelgrim, C. E., Peterson, J. D., Gosker, H. R., Schols, A. M. W. J., van Helvoort, A., Garssen, J., Folkerts, G., & Kraneveld, A. D. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.001 · Cited by 85
“It is believed that gut inflammation in IBD is driven by an inefficient immune response to bacterial antigens, largely regulated by the gut microbiome (Abraham and Cho, 2009).”
Background
Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway
Liu, Q., Zuo, R. M., Wang, K., Nong, F., Fu, Y.-J., Huang, S., Pan, Z., Zhang, Y., Luo, X., Deng, X., et al. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0335-4 · Cited by 78
Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt
Esmat, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i3.814 · Cited by 78
Murine Models of Inflammatory Bowel Disease (IBD)
DeVoss, J., & Diehl, L. J. (2013) · Toxicologic Pathology · doi:10.1177/0192623313509729 · Cited by 78
The ACCURE-trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicenter trial (NTR2883) and the ACCURE-UK trial: a randomised external pilot trial (ISRCTN56523019)
Gardenbroek, T. J., Pinkney, T. D., Sahami, S., Morton, D. G., Buskens, C. J., Ponsioen, C. Y., Tanis, P. J., Löwenberg, M., BRINK, G. R. V. D., Broeders, I. A. M. J., et al. (2015) · BMC Surgery · doi:10.1186/s12893-015-0017-1 · Cited by 78
Helicobacter pyloriinfection and inflammatory bowel disease in Asians: A meta-analysis
Wu, X., Ji, H., Yang, M., Wu, L., & Wang, F. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i15.4750 · Cited by 78
Cytokine responses and epithelial function in the intestinal mucosa
Onyiah, J. C., & Colgan, S. P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2289-8 · Cited by 86
The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases
de Bruyn, M., Vandooren, J., Ugarte-Berzal, E., Arijs, I., Vermeire, S., & Opdenakker, G. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1199535 · Cited by 81
Anti-Inflammatory and Anti-Oxidative Effects of luteolin-7-O-glucuronide in LPS-Stimulated Murine Macrophages through TAK1 Inhibition and Nrf2 Activation
Cho, Y.-C., Park, J., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062007 · Cited by 80
Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy
Xu, C., Chen, S., Chen, C., Ming, Y., Du, J., Mu, J., Luo, F., Huang, D., Wang, N., Lin, Z., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121884 · Cited by 77
Novel perspectives on therapeutic modulation of the gut microbiota
McCarville, J. L., Caminero, A., & Verdu, E. F. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16637819 · Cited by 78
The T300A Crohn’s disease risk polymorphism impairs function of the WD40 domain of ATG16L1
Boada-Romero, E., Serramito-Gómez, I., Sacristán, M. P., Boone, D. L., Xavier, R. J., & Pimentel‐Muiños, F. X. (2016) · Nature Communications · doi:10.1038/ncomms11821 · Cited by 80
Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes
Lahiri, A., Hedl, M., Yan, J., & Abraham, C. (2017) · Nature Communications · doi:10.1038/ncomms15614 · Cited by 76
Dietary practices and inflammatory bowel disease
Limdi, J. K. (2018) · Indian Journal of Gastroenterology · doi:10.1007/s12664-018-0890-5 · Cited by 77
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
Kang, Y. H., Biswas, A., Field, M., & Snapper, S. B. (2019) · Nature Communications · doi:10.1038/s41467-019-08743-8 · Cited by 76
Nod2: a key regulator linking microbiota to intestinal mucosal immunity
Biswas, A., Petnicki‐Ocwieja, T., & Kobayashi, K. S. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0802-y · Cited by 76
3,3′-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction
Huang, Z. D., Jiang, Y., Yang, Y., Shao, J., Sun, X., Chen, J., Dong, L., & Zhang, J. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.09.007 · Cited by 78
Creatine maintains intestinal homeostasis and protects against colitis
Turer, E. E., McAlpine, W., Wang, K.-W., Lu, T., Li, X., Tang, M., Zhan, X., Wang, T., Zhan, X., Bu, C.-H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621400114 · Cited by 76
Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease
Forkel, M., & Mjösberg, J. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0652-3 · Cited by 75
Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
Pagnini, C., Pizarro, T. T., & Cominelli, F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00671 · Cited by 75
“Crohn’s disease (CD) and ulcerative colitis (UC) are the two main entities of IBD, which each presents particular clinical and anatomo-pathological features (Abraham and Cho, 2009).”
Background
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
Wilson, A. S., Almousa, A. A., Teft, W. A., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-58644-w · Cited by 75
Causal association between celiac disease and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study
Yuan, S., Kim, J. H., Xu, P., & Wang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057253 · Cited by 79
“It has more superficial inflammation than CD (3, 4).”
Background
Key questions to guide a better understanding of host–commensal microbiota interactions in intestinal inflammation
Sartor, R. B. (2011) · Mucosal Immunology · doi:10.1038/mi.2010.87 · Cited by 75
Neutrophil-to-lymphocyte ratio in inflammatory bowel disease – As a new predictor of disease severity
Acartürk, G., Acay, A., Demir, K., Mennune Sena, U. L. U., Ahsen, A., & Yüksel, Ş. (2015) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2015_041 · Cited by 77
“In contrast, UC is typifi ed by mucosal infl ammation and limited to the colon (2).”
Background
Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD
Faye, A. S., Wen, T., Soroush, A., Ananthakrishnan, A. N., Ungaro, R. C., Lawlor, G. O., Attenello, F. J., Mack, W. J., Colombel, J., & Lebwohl, B. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06746-w · Cited by 74
Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn’s Disease
Horowitz, J. E., Warner, N. E., Staples, J. C., Crowley, E., Gosalia, N., Murchie, R., Hout, C. V. V., Fiedler, K. B., Welch, G., King, A. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84938-8 · Cited by 80
Visceral fat and gut inflammation
Drouet, M., Dubuquoy, L., Desreumaux, P., & Bertin, B. (2011) · Nutrition · doi:10.1016/j.nut.2011.09.009 · Cited by 75
Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease
Jädert, C., Phillipson, M., Holm, L., Lundberg, J. O., & Borniquel, S. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.012 · Cited by 73
Diagnosis and management of microscopic colitis: current perspectives
Tysk, C., Bohr, J., Wickbom, A., Hegedűs, Á., Nyhlin, N., & Hörnquist, E. H. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s63905 · Cited by 73
Dysbiotic gut microbiome: A key element of Crohn's disease
Øyri, S. F., Műzes, G., & Sípos, F. (2015) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2015.10.005 · Cited by 78
Food avoidance in patients with inflammatory bowel disease: What, when and who?
Bergeron, F., Bouin, M., D’Aoust, L., Lemoyne, M., & Presse, N. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.03.010 · Cited by 73

Authors: Abraham, C., & Cho, J. H.
Affiliations: Yale University (US)
ORCID: Abraham, Clara
Cho, Judy H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2009-11-19
Volume: 361
Issue: 21
Pages: 2066-2078
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra0804647
PMC: PMC3491806
OpenAlex: W4244626580
Cited by: 2,712
References: 104
Citations by year: 2026: 94 · 2025: 137 · 2024: 169 · 2023: 151 · 2022: 171 · 2021: 184 · 2020: 237 · 2019: 189 · 2018: 193 · 2017: 182 · 2016: 171 · 2015: 217 · 2014: 174 · 2013: 142 · 2012: 120
FWCI: 9.21
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Crohn's and Colitis Foundation of America (DK062422, R01DK077905)
Crohn's and Colitis Foundation
National Institutes of Health (DK P30-34989, U01 DK62429)
Takeda Oncology
National Institute of Diabetes and Digestive and Kidney Diseases (DK P30 34989, U01-DK62429, R01DK072373, R01DK077905, RC1DK086800, U01DK062429, P30DK034989, U01DK062422)
National Center for Research Resources (UL1RR024139)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Health Sciences › Medicine › Dermatology › Autoimmune and Inflammatory Disorders
Keywords: inflammatory bowel disease
MeSH terms: Animals, Colitis, Ulcerative, Crohn Disease, Humans, Immunity, Innate, Intestinal Mucosa, T-Lymphocytes, Inflammatory Bowel Diseases, Interleukin-23, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammatory Bowel Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks